COPENHAGEN, Denmark, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that its Board of Directors has authorized the Company to use approximately $25 million to ...
COPENHAGEN, Denmark, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced financial results ...
The Trump administration's decision to pause enforcement of an anti-bribery law raised the specter that drugmakers could engage in bad behavior as a result.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback